Literature DB >> 16848669

Memantine for disruptive behavior in autistic disorder.

Craig A Erickson, Joanna E Chambers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16848669     DOI： 10.4088/jcp.v67n0619h

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  12 in total

1.  In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism.

Authors:  Silvia Bernardi; Evdokia Anagnostou; Jun Shen; Alexander Kolevzon; Joseph D Buxbaum; Eric Hollander; Patrick R Hof; Jin Fan
Journal:  Brain Res       Date:  2010-12-23       Impact factor: 3.252

2.  TARGETED TREATMENTS IN AUTISM AND FRAGILE X SYNDROME.

Authors:  C Kağan Gürkan; Randi J Hagerman
Journal:  Res Autism Spectr Disord       Date:  2012-10-01

3.  A retrospective study of memantine in children and adolescents with pervasive developmental disorders.

Authors:  Craig A Erickson; David J Posey; Kimberly A Stigler; Jennifer Mullett; Adrian R Katschke; Christopher J McDougle
Journal:  Psychopharmacology (Berl)       Date:  2006-10-03       Impact factor: 4.530

4.  A randomized controlled pilot trial of oral N-acetylcysteine in children with autism.

Authors:  Antonio Y Hardan; Lawrence K Fung; Robin A Libove; Tetyana V Obukhanych; Surekha Nair; Leonore A Herzenberg; Thomas W Frazier; Rabindra Tirouvanziam
Journal:  Biol Psychiatry       Date:  2012-02-18       Impact factor: 13.382

5.  Targeting of glycine site on NMDA receptor as a possible new strategy for autism treatment.

Authors:  Ahmad Ghanizadeh
Journal:  Neurochem Res       Date:  2011-01-06       Impact factor: 3.996

6.  Open-label memantine in fragile X syndrome.

Authors:  Craig A Erickson; Jennifer E Mullett; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2009-07-16

Review 7.  Developing drugs for core social and communication impairment in autism.

Authors:  David J Posey; Craig A Erickson; Christopher J McDougle
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2008-10

Review 8.  Emerging pharmacologic treatment options for fragile X syndrome.

Authors:  Tori L Schaefer; Matthew H Davenport; Craig A Erickson
Journal:  Appl Clin Genet       Date:  2015-04-07

Review 9.  The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review.

Authors:  Daniel A Rossignol; Richard E Frye
Journal:  Front Pediatr       Date:  2014-08-22       Impact factor: 3.418

Review 10.  Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.

Authors:  Carolyn A Doyle; Christopher J McDougle
Journal:  Dialogues Clin Neurosci       Date:  2012-09       Impact factor: 5.986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.